21472-86-6

Basic information

• Product Name: 3,4,5-Trichlorotoluene
• Synonyms: 3,4,5-Trichlorotoluene
• CAS NO: 21472-86-6
• Molecular Formula: C₇H₅Cl₃
• Molecular Weight: 195.47
• Mol File: 21472-86-6.mol
• Article Data: 1

Chemical Properties

• Melting Point: 45.5°C
• Boiling Point: 230.4°C (estimate)
• Appearance: /
• Density: 1.3950 (estimate)
• Refractive Index: 1.5670 (estimate)
• CAS DataBase Reference: 3,4,5-Trichlorotoluene(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4,5-Trichlorotoluene(21472-86-6)
• EPA Substance Registry System: 3,4,5-Trichlorotoluene(21472-86-6)

Safety Data

• Hazardous Substances Data: 21472-86-6(Hazardous Substances Data)

Usage

General Description

3,4,5-Trichlorotoluene, also known as TNT-3, is a highly toxic and potentially carcinogenic chemical compound. It is a colorless liquid with a strong, sweet odor, and is used primarily as a solvent in the production of pesticides, herbicides, and other agricultural chemicals. 3,4,5-Trichlorotoluene is also used as a intermediate in the manufacture of dyes, pharmaceuticals, and rubber chemicals. It is considered to be a hazardous substance by the Environmental Protection Agency (EPA), and exposure to 3,4,5-Trichlorotoluene can result in skin and eye irritation, respiratory problems, and damage to the liver and kidneys. It is important to handle and store this chemical with care to prevent harm to human health and the environment.

Upstream product

• 7520-67-4 3,4,5-trichloro-benzyl alcohol 
• 21473-09-6 1-[(1R,3S)-1,2,2,3-Tetrachloro-3-(2-oxo-propyl)-cyclopropyl]-propan-2-one 
• 13711-29-0 2,3-dichloro-5-methylphenylamine 
• 56461-98-4 2,6-dichloro-4-methylaniline 

Downstream Products

• 7520-67-4 3,4,5-trichloro-benzyl alcohol 
• 51-39-8 3,4,5-trichlorobenzoic acid 
• 1006-32-2 2,3,4,5-tetrachloro-toluene 
• 101084-07-5 3,4,5-trichlorobenzylamine 
• 79185-27-6 3,4,5-trichlorobenzyl chloride 

Relevant articles and documents

Pharmacologically active CNS compound

The invention provides a series of compounds of formula (I) and salts thereof, wherein for example,R1 and R2, which may be the same or different each represent -NR13R14 where R13 and R14 may each independently represent hydrogen or alkyl or, taken together with the nitrogen atom to which they are attached form a heterocyclic ring, optionally substituted by one or more alkyl or arylalkyl groups and optionally containing a further heteroatom;, R3 is hydrogen, haloalkyl, alkoxymethyl or alkyl;, R4 is hydrogen, nitro or halo;, R5 is hydrogen or halo;, R6 is hydrogen, halo, nitro, amino, alkylamino or dialkylamino;, R7 is hydrogen or halo;, R8 is hydrogen or halo; The compounds may be used for the treatment or prophylaxis of a neurodegenerative or other neurological disorder of the CNS, the aetiology or which includes excessive release of the neurotransmitter glutamate.